Upcoming Event: Generics R&D Asia 2010
5/13/2010
Event: Generics R&D Summit Asia 2010
Date(s): October 13 - 15, 2010
Venue: Eton Hotel, Shanghai, China
Weblink: http://broadsharegroup.com/generics2010/en/
Contact: Luke Lv
Tel: +86 21 6429 9855 ext. 801
To promote the development of generic drugs and to meet the industrial requirements for developing new market, partnership, and exchanging ideas on the needs of new technologies, the Generics R&D Asia 2010 will be jointly held by BroadShare Business Consulting, Indian Drug Manufacturer's Association (IDMA) in this October in Shanghai. The experts from pharmaceutical companies, research institutes, CROs, hospitals, equipment suppliers, service providers and other related industries will be invited to discuss topics concerning R&D strategic cooperation, research outsourcing, IP protection, API supply and etc. This summit will have four streams on Pharma R&D strategy, Clinical Trials, Reproduction and Innovation of Bio-medicine, Reproduction and Innovation of Chemical Medicine and Traditional Chinese Medicine, along with a project fair with the purpose of a comprehensive in-depth analysis of the market of generics innovation.
Broadshare Group is the leading professional knowledge sharer and conference provider in the Asia-Pacific Region. As a world-class professional intelligence provider, Broadshare Group offers world-wide business executives a platform to broaden their horizon and increase their professional insights.
Event Highlights
The Global Market Is Focusing On China
The huge market demand generated by the medical reform of RMB 850 billion in China is prompting foreign pharmaceutical companies to step up their development in Chinese market, Since the establishment of Eli Lilly's R&D Chinese headquarter in Shanghai, Europe's largest pharmaceutical group Sanofi - Aventis set up it's world fourth-largest R & D center in Beijing. Business of the R&D center is involved in drug development and clinical studies and others. Bayer also set up the worldwide R & D center in Beijing.
Companies of the oversea delegates who attend Generics R&D Summit Asia Summit 2010 include: pharmaceutical companies, bio-pharmaceutical companies, contract manufacturing organizations, contract research organizations, law firms, information and data analysis, suppliers, VC and others, which come from more than 20 countries, such as: United States, United Kingdom, France, Italy, Spain, Portugal, Switzerland, Denmark, Iceland, Israel, India, Japan, South Korea.
Top Generics Companies Turn Up
For the Chinese pharmaceutical companies with the view of grabbing market share in Europe, American and even the whole world as well, the technology and successful experience shared by famous generics companies including: Teva, Sandoz, Actavis, Alvogen, Wockhardt, Ranbaxy and etc. is the most attractive. China's top pharmaceutical companies such as: North China Pharmaceutical Company, Tasly Group, Heng Rui Medicine, Fosun Pharma, Sinopharm, also discuss innovation of generics R&D, market expansion and other issues of common concern.
Unique And Tailor-made Project Fair
R&D outsourcing and technology transfer are the development trend for today's pharmaceutical industry. The project fair in the three-day summit surely provides peers in the pharmaceutical industry with a desirable platform to seek suitable partnership.